Subscribe
Advertise
Wave Neuroscience’s MeRT Gains FDA Clearance for Adult PTSD on the First Sham-Controlled Trial in the Category. The 510(k) Summary Details the Trial Results, the Safety Profile, and the Reimbursement Path Ahead.

Wave Neuroscience’s MeRT Gains FDA Clearance for Adult PTSD on the First Sham-Controlled Trial in the Category. The 510(k) Summary Details the Trial Results, the Safety Profile, and the Reimbursement Path Ahead.

by | Sep 8, 2026 | Technology

Wave Neuroscience’s MeRT System is FDA cleared as an adjunct for adult PTSD. Inside the trial results, the safety profile, and the reimbursement path ahead. Key TakeawaysA real evidentiary first, on a broad indication: FDA cleared the MeRT System on June 3, 2026 as an...
Objective Data and AI Are Reshaping Behavioral Health: Vendors Are Pushing Measurement Into a Field Built on Clinical Judgment. The Clinicians Using These Tools Say the Data Should Sharpen Care, Not Replace It.

Objective Data and AI Are Reshaping Behavioral Health: Vendors Are Pushing Measurement Into a Field Built on Clinical Judgment. The Clinicians Using These Tools Say the Data Should Sharpen Care, Not Replace It.

by | Jun 14, 2026 | Regulation

Key Takeaways The problem: Behavioral health has long relied on subjective assessment and manual documentation, leaving providers exposed to claim denials, audit risk, and uneven clinical quality as payers tighten scrutiny. The response: Companies showcased at...